Fidelity Disruptive Medicine ETF (NASDAQ:FMED – Get Free Report) traded up 1% during mid-day trading on Tuesday . The stock traded as high as $26.57 and last traded at $26.38. Approximately 10,504 shares traded hands during trading, a decline of 16% from the average daily volume of 12,565 shares. The stock had previously closed at $26.12.
Fidelity Disruptive Medicine ETF Price Performance
The firm’s fifty day simple moving average is $25.19 and its 200 day simple moving average is $25.86. The company has a market capitalization of $63.57 million, a price-to-earnings ratio of 41.33 and a beta of 0.82.
Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF
Several hedge funds have recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC grew its position in Fidelity Disruptive Medicine ETF by 4.6% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 714,991 shares of the company’s stock worth $19,712,000 after purchasing an additional 31,629 shares in the last quarter. Jane Street Group LLC lifted its holdings in shares of Fidelity Disruptive Medicine ETF by 95.4% in the fourth quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock valued at $2,473,000 after purchasing an additional 44,630 shares in the last quarter. BXM Wealth LLC purchased a new stake in shares of Fidelity Disruptive Medicine ETF in the fourth quarter valued at $243,000. Vise Technologies Inc. acquired a new stake in shares of Fidelity Disruptive Medicine ETF in the fourth quarter worth $234,000. Finally, Virtu Financial LLC acquired a new stake in shares of Fidelity Disruptive Medicine ETF in the fourth quarter worth $228,000.
About Fidelity Disruptive Medicine ETF
The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.
See Also
- Five stocks we like better than Fidelity Disruptive Medicine ETF
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Fidelity Disruptive Medicine ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fidelity Disruptive Medicine ETF and related companies with MarketBeat.com's FREE daily email newsletter.
